IJE Advance Access originally published online on January 13, 2005
International Journal of Epidemiology 2005 34(1):130-131; doi:10.1093/ije/dyh402
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IJE vol.34 no.1 © International Epidemiological Association 2005; all rights reserved.
Commentary |
Commentary: Death in the era of potent antiretroviral therapy: shifting causes, new challenges
1 Division of Epidemiology and Biostatistics, Department of Social and Preventive Medicine, University of Bern, Switzerland
2 Copenhagen HIV Programme (044), Hvidovre University Hospital, Denmark
* Corresponding author. Department of Social and Preventive Medicine, University of Bern, Switzerland. E-mail: zwahlen@ispm.unibe.ch
| The first 10% of the full text of this article appears below. |
Several studies have shown that the introduction of highly active antiretroviral therapies (HAART) has lead to a substantial reduction in HIV-associated mortality.14 This in turn has resulted in a notable shift in causes of death among adults who died with or due to HIV infection.511 In this issue Lewden et al. present the results of a nation-wide survey of the causes of death of 964 HIV-infected individuals who died in the
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Lohse, A.-B. E. Hansen, G. Pedersen, G. Kronborg, J. Gerstoft, H. T. Sorensen, M. Vaeth, and N. Obel Survival of Persons with and without HIV Infection in Denmark, 1995-2005 Ann Intern Med, January 16, 2007; 146(2): 87 - 95. [Abstract] [Full Text] [PDF] |
||||
